关注
朱伟雄
朱伟雄
The Second Clinical Medical College, Lanzhou University
在 lzu.edu.cn 的电子邮件经过验证
标题
引用次数
引用次数
年份
STAT3 inhibitors: a novel insight for anticancer therapy of pancreatic cancer
X Li, W Jiang, S Dong, W Li, W Zhu, W Zhou
Biomolecules 12 (10), 1450, 2022
192022
The association between Life's Essential 8 and all-cause, cancer and non-cancer mortality in US Cancer Survivors: A retrospective cohort study of NHANES
C Fan, W Zhu, Y He, M Da
Preventive Medicine 179, 107853, 2024
92024
Neutrophil extracellular traps regulating tumorimmunity in hepatocellular carcinoma
W Zhu, C Fan, S Dong, X Li, H Chen, W Zhou
Frontiers in Immunology 14, 1253964, 2023
32023
A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancer
H Chen, N Xu, J Xu, C Zhang, X Li, H Xu, W Zhu, J Li, D Liang, W Zhou
Frontiers in Molecular Biosciences 10, 1298077, 2023
32023
术前中性粒细胞与淋巴细胞比值对胰腺癌手术患者预后价值的 Meta 分析
李宛成, 姜文凯, 朱伟雄, 周文策
中国普通外科杂志 32 (3), 346-356, 2023
12023
Glucose Metabolism Reprogramming of Immune Cells in the Microenvironment of Pancreatic and Hepatobiliary Cancers
Y Zhao, W Zhu, S Dong, H Zhang, W Zhou
Journal of Gastroenterology and Hepatology, 2025
2025
Therapeutic targets for hepatocellular carcinoma identified using proteomics and Mendelian randomization
W Zhu, C Fan, B Liu, J Qin, A Fan, Z Yang, H Zhang, W Zhou
Journal of Gastroenterology and Hepatology, 2025
2025
系统目前无法执行此操作,请稍后再试。
文章 1–7